3 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
Follow Immunoglobulin A Nephropathy: new trials by email Literature Review of Immunoglobulin A Nephropathy trials Research Report on Immunoglobulin A Nephropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN) BCX9930 - Complement 3 Glomerulopathy, Immunoglobulin A Nephropathy | Phase 2 | Terminated | BioCryst Pharmaceuticals | 2 | 2022-02-18 | 2024-05-02 |
| Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) ALXN2050, Placebo - Lupus Nephritis, Immunoglobulin A Nephropathy | Phase 2 | Terminated | Alexion Pharmaceuticals, Inc. | 100 | 2022-01-14 | 2025-10-15 |
| Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) Ravulizumab, Placebo, Background Therapy - Lupus Nephritis, Immunoglobulin A Nephropathy | Phase 2 | Terminated | Alexion Pharmaceuticals, Inc. | 123 | 2021-01-19 | 2026-01-22 |
Glomerulonephritis, IGA (3) · Lupus Nephritis (2) · Glomerulonephritis (1) · Glomerulonephritis, Membranoproliferative (1) · Glomerulonephritis, Membranous (1)
Autoimmune Diseases (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Immune System Diseases (3) · Kidney Diseases (3) · Male Urogenital Diseases (3) · Nephritis (3) · Urogenital Diseases (3) · Urologic Diseases (3) · Connective Tissue Diseases (2) · Glomerulonephritis (2) · Lupus Erythematosus, Systemic (2) · Skin and Connective Tissue Diseases (2)
ravulizumab (1) · rhoA GTP-Binding Protein (1)
Alexion Pharmaceuticals, Inc. (2) · BioCryst Pharmaceuticals (1)
Italy (3) · Spain (3) · United Kingdom (3) · Australia (2) · France (2) · Germany (2) · South Korea (2) · Taiwan (2) · United States (2) · Argentina (1) · Brazil (1) · Canada (1) · China (1) · Israel (1) · Mexico (1)
Carla M Nester, MD, MSA, FASN (1)